Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

K. Khalimova

40 та иш

Tashkent medical academy, Neurology, Tashkent, Uzbekistan

  1. Clinical and non-clinical factors influence the quality of life in patients with striatal hyperkinesis

    R. Juraev, Rustambek Matmurodov, K. Khalimova

    МақолаNeurological and metabolic disordersJournal of the Neurological Sciences20210 иқтибос
    ABI

  2. Anxiety-depressive disorders in women with migraine

    Nilufar Rashidova, K. Khalimova, G. Rakhmatullaeva +1

    МақолаMigraine and Headache StudiesJournal of the Neurological Sciences20210 иқтибос
    ABI

  3. Striatal hyperkinesis and neuron specific protein S100B

    O. Naimov, Rustambek Matmurodov, K. Khalimova

    МақолаS100 Proteins and AnnexinsJournal of the Neurological Sciences20210 иқтибос
    ABI

  4. Influencing factors on cognitive function in Parkinson's disease

    B. Muminov, Rustambek Matmurodov, E. Abdukodirov +1

    МақолаParkinson's Disease Mechanisms and TreatmentsJournal of the Neurological Sciences20210 иқтибос
    ABI

  5. The role of BDNF in the clinical course of primary headaches

    Bahtigul Holmuratova, Nilufar Rashidova, K. Khalimova +2

    МақолаMigraine and Headache StudiesCephalalgia Reports20230 иқтибос
    ABI

  6. Neurological complications after covid-19 vaccination

    K. Khalimova, Nilufar Rashidova, Javlon Salimjonov

    МақолаSARS-CoV-2 and COVID-19 ResearchS S Korsakov Journal of Neurology and Psychiatry20230 иқтибос
    ABI

  7. Specific features of behavioral disorders in Parkinson's disease

    O. Naimov, R. Matmurodov, K. Khalimova +1

    МақолаAutism Spectrum Disorder ResearchParkinsonism & Related Disorders20240 иқтибос
    ABI

  8. Transformation of clinical forms and stages of Parkinson's disease against the background of Covid-19 infection

    R. Matmurodov, B. Muminov, K. Khalimova +3

    МақолаParkinson's Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20240 иқтибос
    ABI

  9. Analysis of risk factors affecting the development of vascular parkinsonism by gender

    B. Amonov, R. Juraev, Rustambek Matmurodov +2

    МақолаNeurological Disorders and TreatmentsParkinsonism & Related Disorders20240 иқтибос
    ABI

  10. The role of brain-derived neurotrophic factor during Parkinson's disease

    Bahtigul Holmuratova, Nilufar Rashidova, K. Khalimova +1

    МақолаAutism Spectrum Disorder ResearchParkinsonism & Related Disorders20240 иқтибос
    ABI

  11. Changes in NO-system parameters in vascular parkinsonism

    R. Juraev, R. Matmurodov, K. Khalimova

    МақолаNeurological Disease Mechanisms and TreatmentsParkinsonism & Related Disorders20240 иқтибос
    ABI

  12. Neurological Complications after COVID-19 Vaccination

    K. Khalimova, Nilufar Rashidova, Javlon Salimjonov

    МақолаPeripheral Neuropathies and DisordersNeuroscience and Behavioral Physiology20240 иқтибос
    ABI

  13. Topiramate and metoprolol in the preventive treatment of chronic migraine

    Bahtigul Holmuratova, Nilufar Rashidova, Gulzoda Nurmakhammatova +1

    МақолаMigraine and Headache StudiesJournal of the Neurological Sciences20250 иқтибос
    ABI

  14. ABSTRACT NUMBER: ESOC2026A1733 THE COURSE AND CONSEQUENCES OF STROKE IN THE CITY OF NUKUS, REPUBLIC OF KARAKALPAKSTAN BASED ON THE REGISTER

    R. Juraev, R J Matmurodov, K. Khalimova +1

    МақолаAcute Ischemic Stroke ManagementEuropean Stroke Journal20260 иқтибос
    ABI

  15. ABSTRACT NUMBER: ESOC2026A1995 FEATURES OF NON-MOTOR DISORDERS IN VASCULAR PARKINSONISM

    Shodlik Jumaniyozov, R J Matmurodov, R. Juraev +2

    МақолаNeurological Disorders and TreatmentsEuropean Stroke Journal20260 иқтибос
    ABI